With the push to encourage researchers to take steps to commercialize their discoveries, there are grants and awards and tech transfer offices and incubators and competitions and…
But receiving money doesn’t automatically mean that a successful business will appear right away. Like all startups, they need to identify the potential market for a product, and come up with a plan.
That’s where Thomas Starr and Mark Peters of Chesapeake Visions come in. Working out of Spark Baltimore, the duo are helping startups who receive funding from TEDCO’s Maryland Innovation Initiative (MII) with market research.
A specific portion of the MII funding has to be set aside for commercialization planning. Starr and Peters identified an opportunity for a venture around that work while doing market research for Ken Malone of Early Charm Ventures.
They gather data about a potential market for a product, talk to potential customers and evaluate intellectual property. It’s the kind of work that doesn’t always grab the spotlight and takes a lot of work, and it’s an area that scientists may not always understand.
But the “unsexy market research,” says Starr, shows the reality of a potential business, and can ultimately help shape future investment.
One business they’ve been working with is Asulon Therapeutics. The University of Maryland spinout company is developing small-molecule therapeutics to treat depression, and received TEDCO funding. Founder Adam Van Dyke said juggling the venture and a day job left him time-limited, and he found Starr had a lot more experience in doing market research.
“He took work that would’ve taken me three times to do, and he did it in a week,” Van Dyke said.
The work ultimately led to a new venture, too. Van Dyke is now also working on an app that tracks symptoms related to depression, called InSu.
“We realized that it had a much larger potential than we initially thought,” Van Dyke said.
MindX, a startup developing brain-controlled smartglasses, names Julia Brown as CEO
UMB inks second licensing deal with spinout developing cancer treatments
Immunotherapy startup moves into the University of Maryland BioPark
Pitch to speak at Comcast Labs Connect’s data security conference
Gemstone Biotherapeutics receives $225K from ‘America’s Seed Fund’
Bluefield Innovations thinks this JHU cancer research could become a new Baltimore company
University of Maryland spinout Harpoon Medical acquired in $100M deal
Arrive ready to grow at 14 West
Sign-up for daily news updates from Technical.ly Baltimore